Suzanne Pfeffer

Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds Stanford Medicine-led research in mice indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson’s disease.

med.stanford.edu/news/all-new...

01.07.2025 21:23 — 👍 4    🔁 2    💬 0    📌 0

Coalition Statement on the Impact and Safety of Vaccines   - AAI News Statement on the impact and safety of vaccines led by the American Association of Immunologists and the American College of Physicians.

news.aai.org/2025/03/18/c...

27.03.2025 20:29 — 👍 0    🔁 0    💬 0    📌 0

Opinion | Universities Gave Us the iPhone, the Jet Engine and Gatorade. We’re Tossing That Away. The postwar compact on research that powered America’s economic and military dominance is under threat.

Columbia’s Capitulation Will Hurt Us All www.nytimes.com/2025/03/24/o...

24.03.2025 22:58 — 👍 1    🔁 0    💬 0    📌 0

Lysosomal Glucocerebrosidase is needed for ciliary Hedgehog signaling: A convergent pathway to Parkinsons disease Mutations in LRRK2 and GBA1 are the most common genetic causes of familial Parkinsons disease. Previously, we showed that pathogenic LRRK2 mutations inhibit primary cilia formation in rare interneuron...

Excited to share our preprint showing loss of Hedgehog signaling in GBA1 mutant cells, converging with LRRK2 mutant phenotypes biorxiv.org/content/earl...
@asapresearch.bsky.social

21.01.2025 19:22 — 👍 5    🔁 0    💬 0    📌 0

Excited to share our recent paper: [Parkinson's linked] Pathogenic LRRK2 mutations cause loss of primary cilia and Neurturin in striatal parvalbumin (PV) interneurons" in mouse and human. DOI 10.26508/lsa.202402922 #Parkinsons @asapresearch.bsky.social @scienceofpd.bsky.social

13.11.2024 19:27 — 👍 8    🔁 1    💬 0    📌 0